ANXA5 and hepatocellular carcinoma: In the liver tissue, ANXA5 reached more than 3000 ng/mg of protein (p < 0.01) from the early HCC stage (W6) and progressively increased to 6000 ng/mg until the late HCC stage, namely W22 (Fig. 5g).